Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Added Value of Preoperative Contrast Enhanced Mammography (PROCEM) in Staging of Malignant Breast Lesions - a Prospective Randomized Multicenter Trial

NCT04437602 is registered in ClinicalTrials.gov with Region Halland as lead sponsor.

NCT NCT04437602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04437602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Added Value of Preoperative Contrast Enhanced Mammography (PROCEM) in Staging of Malignant Breast Lesions - a Prospective Randomized Multicenter Trial
Lead sponsor
Region Halland
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 2, 2020
Completion date
December 31, 2029
Enrollment
441 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer